VIT D3+K2
Food supplement declared in France, declaration No 2020-2-923
VIT D3+K2 (IO GENIX) is a food supplement declared in France. Status: retrait du marché annoncé pour le 23 June 2028. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- IO GENIX
- Food business operator placing the product on the market
- AYOLABS
- Status
- Retrait du marché annoncé pour le 23 June 2028
- Form
- Comprimé
- Daily dose
- 1 comprimé
- Directions for use
- Prendre 1 comprimé par jour avec un verre d’eau.
- Objectives stated by the manufacturer (these are not authorised claims)
- Articulations, Sport
Declaration 216967, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 23 June 2028, according to Compl'Alim.
Source: Compl'Alim, déclarations de compléments alimentaires.
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
| Ménaquinone | Vitamine K | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
Other ingredients
maltodextrine
Has the product changed? Photograph the packaging.
Label warnings
Avertissements: Les compléments alimentaires ne doivent pas être utilisés comme un substitut à une alimentation variée et équilibrée et un mode de vie sain. Ne pas dépasser la dose journalière recommandée. Garder hors de portée des jeunes enfants. Garder bien fermé dans un endroit frais et sec.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.